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1. Introduction 
Organ transplantation is a lifesaving procedure, yet the demand for transplants far exceeds 
the available supply. Each year, nearly seven thousand patients in the United States die 
while waiting for an organ transplant [1]. Developing heart muscles in vitro for 
transplantation [3] [4] is one approach that could ultimately overcome this critical shortage. 
For complex tissues such as a heart muscle, the final product has to mimic physiological 
functions as well as the regulatory system for regenerating the recipient’s tissue functions. 
Successful development of implantable and functional engineered tissues is currently  
hindered by the time-consuming and cost-intensive processes through which developers 
iteratively work to optimize tissue-fabrication protocols, needing to establish proper culture 
conditions and the ideal quantities of materials used. To overcome these burdens, it is 
critical to establish a prototyping process by which the developers can explore many 
parameters rapidly using minimal resources. To achieve this goal, 1) the prototypes of 
engineered tissues have to be small enough to save materials, including cells, extracellular 
matrices and growth factors that are necessary for the in vitro heart tissue development, and 
2) the assay system to evaluate the heart tissue function has to be automated for rapid high-
throughput analysis of prototyping results. In addition, a stable source of cells must be 
carefully selected to maintain the reproducibility of tissue production while scaling up the 
manufacturing capability.  
2. Miniaturizing biological samples and products   
Size of engineered tissue (ET) varies based on research needs. To systematically screen and 
analyze a large number of parameters that determine tissue function, the size of ETs has to 
be defined based on  the required throughputs and phenotying assays for the tissue function 
analysis. Fully-grown cardiac muscle cells in three dimensional matrices are at least 100 um 
in length along their longitudinal axis [5]. Therefore, engineered heart tissues (EHTs) should 
be at least several times larger than the size of single cells in order to form multi-cellular 
functional cardiac muscles. In addition, the statistical significance of data improves 
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significantly when using multi-cellular tissues rather than single cells [6] because the tissue 
samples contain from tens of thousands to over a million cells. The functional assay data 
collected using tissues represents an average function of many cells embedded in the tissues. 
By applying the photolithographical techniques, smaller, micro-scale (50-200 um) 
engineered tissues can be fabricated [7] to mimic intricate shapes of native tissues. However, 
in these micro-scale tissues, it is yet to be determined if there is an improvement of the 
statistical significance of functional data over that from single cells. At present, ETs in 
millimeter scale have been used for the functional assays with relatively good data 
reproducibility [8] [9]. By using ETs, a statistically significant data can be obtained using 
only 4-8 samples [9] instead of collecting ranging 60-600 data points per well in cell-based 
assays [10].  
Unlike the rapid prototyping of parts with synthetic materials, the prototyping of 
engineered tissues with live cells has to consider the behavior of tissues after fabrication in a 
given culture condition. Cells are a vital element of developing functional organs and 
tissues. While consuming nutrients and receiving extracellular stimuli, the cells synthesize, 
secrete, and degrade proteins, divide, and remodel tissues. Therefore, developers of 
engineered tissue have to take these aspects into account for the design and development of 
engineered tissue samples and products. Behaviors of cells have been studied extensively to 
understand the molecular mechanisms by which biological functions of cell are regulated 
[11]. Because the cell behavior should underlie function of tissues and organs, the vast 
amount of information that has been accumulated through studies of cells should be used to 
understand tissue and organ function. However, some recent findings indicate that biology 
of cells cultured in two dimension (2D) is not entirely the same as that of cells cultured in a 
three dimensional (3D) environment, which is more similar to the in vivo environment in 
which cells reside.   
3. 2D vs 3D cell based analysis   
Even though cells cultured on a 2D surface have been assumed to closely resemble those 
in tissues and organs, in some aspects they are quite different from those found in vivo. In 
vivo, most cells are found embedded within a 3D extracellular matrix (ECM), and their 
shape and cell-ECM adhesion are different from those in 2D culture [12]. In most 2D cell 
culture, cells are cultured on infinitely stiff solids. However, in 3D culture, the ECM in 
which native cells reside can be deformed, stiffened, softened, or degraded to change the 
mechanics of the tissue. Stem cell linage specification has been observed to be directed by 
matrix stiffness [13], which strongly suggests that mechanical signaling will play a pivotal 
role in developing physiologically functional and implantable tissues. A difference in 
mechanical signal transduction between a 2D and a 3D environment was also suggested 
[14]. For instance, fibroblasts cultured in 3D have intrinsically lower expression levels of 
the small GPTase Rac than those in 2D cultured cells, which switches the migratory 
pattern of cells from random to persistent [15]. Reduction of the activity of focal adhesion 
kinase (FAK) and ERK1/2 in 3D culture, as compared to 2D cultures, has also been 
reported [12]. There is significant concern over the biological differences observed 
between 2D cell-culture systems, which have been used to study almost all signal 
transduction pathways to date [16], and the arguably more physiological 3D cell-culture 
environment.  
www.intechopen.com
Rapid Prototyping  
of Engineered Heart Tissues through Miniaturization and Phenotype-Automation 
 
51 
When testing mechanical signaling, the tissues are subjected to mechanical deformations 
including pushing and stretching. An application of cyclic mechanical stretch to cardiac 
myocytes and fibroblasts up-regulates various signal transduction pathways through 
Rho/ROCK activation [17, 18]. Activation of extracellular signal-regulated kinases (ERKs) 
and up-regulation of an immediate early gene family of transcription factors, and c-fos [19] 
are well-characterized early responses of cells to the stretching. Up-regulated cellular 
processes including protein synthesis [20] and myofibril organization [21] are also apparent. 
The Rho/ROCK signaling pathway also regulates a hypertrophic response in cultured 
cardiac myocytes after application of soluble factors such as endothelin-1 treatment [22]. 
Therefore, an intricate balance orchestrated by soluble stimuli, mechanical deformation, and 
extracellular stiffness dictates the tissue development. 
The tissue can function normally under homeostasis, at which the mechanical balance 
between extra- and intra-cellular activities is balanced. The homeostasis can be shifted by 
aging or other long term processes but is a quasi-steady state that is required for a tissue’s 
physiological function. For example, physiological wound healing restores the homeostasis 
in the granulation tissue – fibrous connective tissue of healing wounds – by active 
fibroblasts contracting open wounds, secreting factors and hormones, and degrading ECMs 
to reconstruct the damaged tissues [23]. Pathological wound healing, such as keloids and 
scars in skin [24], fails to restore the homeostasis. A schematic description of potential 
network system is in shown in Figure 1. Intracellular molecular sensors, such as the src 
family kinase substrate p130Cas [25], detect the stiffness of extracellular environment to 
initiate its down-stream signaling events including Ca2+ release, kinase activity, and gene 
regulation. Expressions of various genes are up-regulated through translocation of 
transcription factors from cytoplasm into nucleus. Furthermore the gene expression can be 
coupled to cell contraction. For instance, during the formation of actin stress-fibers in 
contracting fibroblasts, the balance of actin pools is shifted from a high prevalence of the 
monomer state to increased polymer levels. This balance shift frees up myocardin-related 
transcription factors (MRTF)-A, which are bound to monomer actins, and the unbound 
MRTF-As translocate into nucleus to promote gene expression. Therefore, MRTF-A’s 
downstream up-regulation of wound healing gene-family including collagen type I a1 is 
tightly coupled to the state of actin polymerization (F- and G- actin ratio) in fibroblasts 
[26].  
In parallel with changing the mechanical environment, the soluble factors, such as TGF ǃ1, 
binding to their specific receptors initiate the similar downstream signaling events [27, 28]. 
Depending on the signaling pathways, the initial signal strength can be amplified. One of 
recent observations indicates that signal strength is amplified in three-tiered kinase module 
of Raf-MEK(mitogen-activated protein kinase or extracellular signal-regulated kinase 
kinase)-ERK (extracellular signal-regulated kinase) by increasing concentrations of kinases 
involving in downstream (e.g., 1:3:6 = raf-1:MEK:ERK) in COS cells [29]. The soluble and 
mechanical stimuli result in the development of contractility by actin-myosin interactions, 
which is one of end-points of the signaling pathways. We hypothesize that the activities of 
actin-myosin interactions is a part of feedback mechanism by which cells sense the 
strength of mechanical stimuli and stiffness of extracellular space [30]. Integrin-linked 
kinase and ECM protein, tenascin-C, have been demonstrated to be a part of the 
mechanical sensory systems in zebrafish heart [31], skeletal muscles [32], and fibroblasts 
[33]. 
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Fig. 1. Regulation of Mechanical Tissue Homeostasis Establishment  
As demonstrated elegantly for p130Cas [25], a simple analogy of the biological sensory 
mechanism is represented as a mechanical strain gauge that measures applied forces by 
detecting small deformations of proteins. Depending on an elastic strength of the gauge 
(i.e., protein), its sensitivity can be varied. In general the sensitivity becomes higher by 
reducing the elasticity of the gauge material since it can deform more with a same applied 
force. We and others [18] assume that the molecular strain gauges are coupled to the 
actin-myosin forming stress fibers whose elasticity or stiffness is modulated by activity of 
myosin. The receptor activation initiated by binding of various soluble factors triggers and 
modulates myosin activity. Therefore, the sensitivity of the mechanical sensor can be 
modulated. Eventually the mechanical properties of cell and extracellular matrix reach a 
steady state to find homeostasis. However, its specific mechanism by which sensors can 
modulate their sensitivity and determination of the homeostasis are yet to be elucidated. 
Nevertheless, the concept of the establishment of homeostasis between the cells and ECM 
comprising “tissue” should be considered carefully while designing and developing the 
functional tissues in vitro. The mechanical properties of engineered tissues have to match 
with donor tissues, especially for those carrying critical mechanical functions including the 
cardiovascular system. As described, varying stiffness of the extracellular environment takes 
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part in dictating stem cell fates [34]. Rapid high throughput tissue phenotyping can be used 
to test various soluble and mechanical stimuli to yield an optimal tissue with desired 
functions. 
4. Cardiac tissue phenotyping and their potential to assay-automation 
The assay system by which developers can evaluate the functional improvement that results 
from optimizing the tissue fabrication and culture conditions will have to accurately observe 
the physiological functions of cardiac tissues. The contractility of cardiac tissues is the most 
fundamental functional readout that can indicate the functional improvement by varying 
the tissue fabrication conditions. The regulatory system of cardiac contractility should also 
be reconstituted in the engineered tissues, which will be evaluated through rapid 
prototyping. As listed in Table 1, EHT-based contractility assessment is ideal for assessing 
cardiac functions in high-throughput, as compared to the other techniques that have 
traditionally been used to assess the function of myocytes, myocardium, and isolated hearts. 
Each method has its own advantages and disadvantages. The assay results using isolated 
adult cells and papillary muscles will continue to serve as references for the expected muscle 
cell and tissue contractility and its regulation. However, they can not report the tissue 
functions. Cardiac contractility assays using isolated Langendorff preparation has been 
gradually replaced by hemodynamic measurements using pressure-volume conductance 
catheters [35] as well as echo cardiography. Nevertheless, the whole heart functional 
assay can be used to assess functional improvement that results from the tissue 
transplantation. 
 
  Engineered 
Heart Tissues 
Isolated Adult 
Cells 
Papillary 
Muscles 
Langendorff 
Preps 
Sample viability period Weeks to months ~6 hrs ~6-8 hrs ~8 hrs 
Contractility 
measurements with 
preload. 
Yes (various) No * Yes (various) Yes (various, 
PV loop) 
Optical assessment of 
live cells 
Yes (easy) Yes (easy) Yes (not easy) No (generally) 
High throughput 
testing 
Yes Yes No No 
Sample damage by 
isolation 
No Yes Yes Yes 
Comments Reconstituted 
system 
High data 
variance 
 Widely used 
standards. 
* Isolated adult cells can be stretched by carbon fiber techniques [2]. High throughput measurements 
and range of stretching are limited.  
Table 1. Comparison of methods for measuring cardiac contractility in vitro 
Once the EHTs start contracting, they maintain contractility for at least 2-3 weeks. 
Assessment of acute and chronic changes in contractility and cell physiology can thus be 
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monitored for long periods using EHTs. Even though EHTs are artificially reconstituted 
organoids, their histological structure and functional properties are similar to those in 
native myocardium [5, 36]. Each EHT is fabricated by pouring a gel solution containing 
predefined concentrations of cells, matrix proteins, and growth factors into a precisely 
machined well [5]. Since 1993, similar engineered tissues have been used as a model 
system to study signal transduction pathways that regulate contractility of fibroblasts 
[37], smooth muscle cells, skeletal muscle cells [8]. We were the first to introduce the use 
of tissue models to determine effective drug doses [38] and have recently extended the 
application of this technology to include phenotypic screening [39]. We demonstrated the 
phenotypic difference in tissue mechanics between wildtype cells and mutant cells with 
truncated ǂ1 integrin [40]. We also extended the applications of engineered tissue models 
by creating cardiac tissue constructs [41]. Recently, we introduced the concept of growing 
mini-tissues in 96-well plates for high-throughput drug screening [42]. Initially 
engineered heart tissues were fabricated using a tissue fabrication mold that cast hydrogel 
into a ring [5]. To miniaturize the tissues, we developed tissue fabrication wells similar to 
those used in 96-well format. The center-to-center distance of 96-well plates is 9 
millimeters. We developed 8mm x 8mm square wells to fabricate the engineered tissues. 
We demonstrated the automation of contractile measurements of EHTs to improve the 
productivity of the proposed studies. The generation of EHTs using pluripotent stem cells 
will open up the new pathways to develop engineered tissues using human cells. 
However, there are several issues that need to be solved before benefitting highly 
promising technology.  
5. Multi cell types require functional cardiac patches using iPSCs 
Human iPSCs, which are generated by genetic reprogramming of somatic cells to an 
infinitely self-renewing pluripotent state [43, 44], offer an excellent source for robust 
generation of large numbers of human cardiac myocytes (CMs), endothelial cells (ECs) and 
fibroblasts (FBs), which are all needed for producing a vital EHT in vitro [45]. Protocols to 
generate somatic cells from hPSCs typically attempt to recapitulate cardiac development in 
an accelerated manner by temporal application of differentiation cues[45]. For example 
directed differentiation protocols that achieve high yield and purity of CMs from human 
pluripotent stem cells apply basic FGF, TGFǃ superfamily ligands, VEGF, and Wnt agonists 
and antagonists at precise differentiation stages [46, 47]. Recently CMs generated from 
human embryonic stem cells (hESCs) have been injected into rodent cardiac muscle; these 
CMs engrafted, survived, and resulted in functional improvement in myocardial infarction 
models [47];[48]. HESC-derived CMs and ECs assembled into spontaneously contracting 
patches and, when implanted on a rodent pericardium, survived and anastomosed [45]. This 
study clearly indicates that multiple cell types are necessary in generating functional cardiac 
patches.  
Because of the requirement of multi cell types to fabricate functional cardiac patches, the 
high throughput rapid prototyping system can contribute to identifying the optimal 
combination of cell types to fabricate the best cardiac patches. Not only varying the number 
of CMs, ECs, and FBs to initiate the fabrication, the response to each cell type to various 
hormones, growth factors, and mechanical environment will have to be screened again to 
find the best combinations. Therefore, a rapid prototyping system that can screen various 
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test conditions will be critically needed to establish functional tissues with desired 
phenotypes.   
6. Summary 
Systematically optimizing a tissue-fabrication protocol will require an iterative process of 
changing the parameters of fabrication and tissue culture conditions incrementally after 
measuring the resulting functional improvement. To test a large number of these parameters 
to the best outcome, many tissues have to be fabricated and their function has to be 
evaluated in high-throughput. To achieve this prototyping cost-effectively, the samples have 
to be miniaturized. Most importantly, establishing the tissue homeostasis in the engineered 
tissue has to be achieved either before implantation or by taking account how tissue 
homeostasis will be established with the acceptor’s existing tissue. In vivo tissue organ 
phenotyping with transplanted tissues will be as important as availability of rapid 
prototyping of engineered tissues.  
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